Ventricular irrigation to treat ventriculitis

Safety and Efficacy of Ventricular Irrigation for Ventriculitis: a Randomized Controlled Trial

Not applicable Interventional RenJi Hospital · NCT06358209

This test will see if flushing infected brain ventricles (ventricular irrigation) helps adults with purulent ventriculitis recover faster and have fewer complications than standard treatment.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment310 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorRenJi Hospital Academic / other
Locations35 sites (Hefei, Anhui and 34 other locations)
Trial IDNCT06358209 on ClinicalTrials.gov

What this trial studies

Ventriculitis is a life-threatening infection of the brain’s ventricular system often associated with neurosurgical devices or procedures and with high mortality and long-term neurological disability. This interventional approach adds surgical ventricular irrigation—flushing and clearing pus from the ventricles, typically via external ventricular access—to standard antimicrobial therapy. The trial enrolls adults with purulent CSF (cloudy or yellow fluid with very high white blood cell counts), fever, and either positive CSF microbiology or CT/MRI evidence of intraventricular pus. Multiple hospitals in Anhui, China, led by RenJi Hospital and academic collaborators will track safety, infection clearance, mortality, and functional neurological outcomes.

Who should consider this trial

Good fit: Adults 18–65 with purulent CSF (cloudy/yellow) and WBC >1000×10^6/L, fever, and either positive CSF microbiology or CT/MRI evidence of intraventricular pus who can tolerate surgical intervention and give consent.

Not a fit: Patients unlikely to benefit include those with a Glasgow Coma Scale of 3, unstable vital signs (no spontaneous breathing or needing pressors), severe bleeding risk that precludes surgery, and pregnant or lactating women.

Why it matters

Potential benefit: If successful, ventricular irrigation could speed clearance of infection, lower mortality, and reduce long-term neurological disability in patients with purulent ventriculitis.

How similar studies have performed: Several recent case series and observational studies suggest ventricular irrigation can speed infection control and may improve outcomes, but high-quality randomized evidence is still limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-65 years old;
* CSF is purulent (it appears cloudy or yellow) and white blood cell count over 1000×10\^6/L.
* Fever (\>38.0°C)
* Meet at least one of the following: 1. Patient has organism(s) identified from CSF by a culture or non-culture based microbiologic testing method; 2. Cranial CT or MRI indicating intraventricular floccule or pus.
* With consent form

Exclusion Criteria:

* With GCS score of 3
* With unstable vital signs such as no spontaneous breathing and blood pressure maintenance drugs
* With severe propensity for bleeding (Such as coagulation dysfunction, active bleeding, etc.), and unable to tolerate the surgical procedures or operations related to ventricular irrigation treatment.
* Pregnant or lactating women

Where this trial is running

Hefei, Anhui and 34 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Central Nervous System InfectionsVentriculitisVentricular irrigation
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.